Evaluation of XYA02 in Patients With Advanced Solid Tumors

NCT07670312 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors
Non-Small Cell Lung Cancer
Ovarian Cancer
GEJ Adenocarcinoma
Colorectal Cancer
Pancreatic Adenocarcinoma
Gastric Cancer

Interventions

BIOLOGICAL: XYA02

Sponsor

XYone Therapeutics, Inc

Collaborators

[object Object]